Ocular Therapeutix, Inc.

OCUL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Assets
Cash & Equivalents $41.5M $32.9M $30.8M $37.4M $17.5M
Accounts Receivable $226.0K $250.0K $193.0K $329.0K $250.0K
Inventory $122.0K $113.0K $134.0K $133.0K —
Total Current Assets $43.3M $69.9M $107.0M $76.2M $18.0M
Property, Plant & Equipment $10.5M $3.3M $3.1M $1.8M $904.0K
Goodwill — — — — —
Intangible Assets (Excl. Goodwill) — — — — —
Total Assets $55.4M $74.9M $110.3M $78.2M $19.1M
Liabilities
Accounts Payable $3.6M $2.1M $2.0M $1.3M $545.0K
Total Current Liabilities $13.4M $8.3M $5.4M $5.9M $3.3M
Long-Term Debt — — — — —
Total Liabilities $29.3M $22.9M $20.7M $19.5M $4.3M
Stockholders' Equity
Retained Earnings $-237.3M $-173.9M $-129.2M $-89.4M $-60.8M
Total Stockholders' Equity $26.1M $52.0M $89.6M $58.7M $-59.5M
← Newer Page 2 of 2 Older →